Micrometastasis-derived models enable drug testing for early-stage, high-risk melanoma patients
Year: 2025
Type: article
Language: en
Topic: Cancer Cells and Metastasis
Authors and affiliations:
raw_author_name: Kathrin Weidele
raw_affiliation_strings: Fraunhofer-Institute for Toxicology and Experimental Medicine, Division of Personalized Tumor Therapy, Am Biopark 9, Regensburg, 93053, Germany
raw_author_name: Christian Werno
raw_affiliation_strings: Fraunhofer-Institute for Toxicology and Experimental Medicine, Division of Personalized Tumor Therapy, Am Biopark 9, Regensburg, 93053, Germany
raw_author_name: Steffi Treitschke
raw_affiliation_strings: Fraunhofer-Institute for Toxicology and Experimental Medicine, Division of Personalized Tumor Therapy, Am Biopark 9, Regensburg, 93053, Germany
raw_author_name: Catherine Botteron
raw_affiliation_strings: Fraunhofer-Institute for Toxicology and Experimental Medicine, Division of Personalized Tumor Therapy, Am Biopark 9, Regensburg, 93053, Germany
raw_author_name: Martin Hoffmann
raw_affiliation_strings: Fraunhofer-Institute for Toxicology and Experimental Medicine, Division of Personalized Tumor Therapy, Am Biopark 9, Regensburg, 93053, Germany
raw_author_name: Sebastian Scheitler
raw_affiliation_strings: Experimental Medicine and Therapy Research, University of Regensburg, Franz-Josef-Strauß-Allee 11, Regensburg, 93053, Germany
raw_author_name: Lukas Wöhrl
raw_affiliation_strings: Fraunhofer-Institute for Toxicology and Experimental Medicine, Division of Personalized Tumor Therapy, Am Biopark 9, Regensburg, 93053, Germany
raw_author_name: Zbigniew Czyz
raw_affiliation_strings: Experimental Medicine and Therapy Research, University of Regensburg, Franz-Josef-Strauß-Allee 11, Regensburg, 93053, Germany
raw_author_name: Giancarlo Feliciello
raw_affiliation_strings: Fraunhofer-Institute for Toxicology and Experimental Medicine, Division of Personalized Tumor Therapy, Am Biopark 9, Regensburg, 93053, Germany
raw_author_name: Florian Weber
raw_affiliation_strings: Institute of Pathology, University of Regensburg, Franz-Josef-Strauß-Allee 11, Regensburg, 93053, Germany
raw_author_name: Adithi Ravikumar Varadarajan
raw_affiliation_strings: Fraunhofer-Institute for Toxicology and Experimental Medicine, Division of Personalized Tumor Therapy, Am Biopark 9, Regensburg, 93053, Germany
raw_author_name: Jens Warfsmann
raw_affiliation_strings: Fraunhofer-Institute for Toxicology and Experimental Medicine, Division of Personalized Tumor Therapy, Am Biopark 9, Regensburg, 93053, Germany
raw_author_name: Silvia Materna-Reichelt
raw_affiliation_strings: Fraunhofer-Institute for Toxicology and Experimental Medicine, Division of Personalized Tumor Therapy, Am Biopark 9, Regensburg, 93053, Germany
raw_author_name: Marie Katzer
raw_affiliation_strings: Department of Dermatology, University Medical Center Regensburg, Franz-Josef-Strauß-Allee 11, Regensburg, 93053, Germany
Experimental Medicine and Therapy Research, University of Regensburg, Franz-Josef-Strauß-Allee 11, Regensburg, 93053, Germany
raw_author_name: Laura Schreieder
raw_affiliation_strings: Department of Dermatology, University Medical Center Regensburg, Franz-Josef-Strauß-Allee 11, Regensburg, 93053, Germany
raw_author_name: Parvaneh Mohammadi
raw_affiliation_strings: Experimental Medicine and Therapy Research, University of Regensburg, Franz-Josef-Strauß-Allee 11, Regensburg, 93053, Germany
raw_author_name: Hedayatollah Hosseini
raw_affiliation_strings: Experimental Medicine and Therapy Research, University of Regensburg, Franz-Josef-Strauß-Allee 11, Regensburg, 93053, Germany
raw_author_name: Kamran Honarnejad
raw_affiliation_strings: Fraunhofer-Institute for Toxicology and Experimental Medicine, Division of Personalized Tumor Therapy, Am Biopark 9, Regensburg, 93053, Germany
raw_author_name: Sebastian Haferkamp
raw_affiliation_strings: Department of Dermatology, University Medical Center Regensburg, Franz-Josef-Strauß-Allee 11, Regensburg, 93053, Germany
raw_author_name: Melanie Werner-Klein
raw_affiliation_strings: Experimental Medicine and Therapy Research, University of Regensburg, Franz-Josef-Strauß-Allee 11, Regensburg, 93053, Germany
raw_author_name: Christoph A Klein
raw_affiliation_strings: Experimental Medicine and Therapy Research, University of Regensburg, Franz-Josef-Strauß-Allee 11, Regensburg, 93053, Germany. christoph.klein@ukr.de
Fraunhofer-Institute for Toxicology and Experimental Medicine, Division of Personalized Tumor Therapy, Am Biopark 9, Regensburg, 93053, Germany. christoph.klein@ukr.de
Experimental Medicine and Therapy Research, University of Regensburg, Franz-Josef-Strauß-Allee 11, Regensburg, 93053, Germany
Fraunhofer-Institute for Toxicology and Experimental Medicine, Division of Personalized Tumor Therapy, Am Biopark 9, Regensburg, 93053, Germany